Transcatheter therapies for severe tricuspid regurgitation. Quo vadis

Herz1.70
Volume: 46, Issue: 3, Pages: 234 - 241
Published: Jun 1, 2021
Abstract
Moderate-to-severe tricuspid regurgitation (TR) is common and is associated with a poor prognosis. To date, most patients are undertreated; therefore, transcatheter options could be clinically impactful in those who are denied surgery. Several transcatheter solutions have been developed that address the problem via leaflet enhancement, annuloplasty, or heterotopic implantation of self-expandable or balloon-expandable valves in the caval veins....
Paper Details
Title
Transcatheter therapies for severe tricuspid regurgitation. Quo vadis
Published Date
Jun 1, 2021
Journal
Volume
46
Issue
3
Pages
234 - 241
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.